![Roger Sawhney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roger Sawhney
Directeur/Membre du Conseil chez
ARBUTUS BIOPHARMA CORPORATION
Fortune : - $ au 31/05/2026
Profil
Roger A. Sawhney is currently Director at SIRPant Immunotherapeutics, Inc. since 2024, Independent Director at Arbutus Biopharma Corp.
starting 2025, Director at Adlai Nortye Ltd. since 2024, Independent Director at Actuate Therapeutics, Inc. since 2024, and Chief Business Officer at Neuvogen, Inc. Former roles include Director at Alimera Sciences, Inc. in 2023, Managing Director & Partner at The Boston Consulting Group, Inc. from 1996 to 2009, Director at KKR Group Co., Inc. from 2018 to 2020, Independent Director at Arcellx, Inc., Director at New York Institute of Technology, SVP-Corporate Strategy & Business Development at ContextMedia Health LLC from 2017 to 2018, Senior VP & Head-Global Corporate Strategy at Novartis AG from 2009 to 2012, Chief Financial Officer at Stratus Therapeutics, Inc. from 2022 to 2023, Partner at Bain & Co., Inc. from 2012 to 2017, Chief Business Officer at Omega Therapeutics, Inc. in 2022, and Chief Financial Officer at LB Pharmaceuticals, Inc. Education includes undergraduate studies at Stanford University and a doctorate from Harvard Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 11/09/2025 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 08/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Roger Sawhney
| Sociétés | Poste | Début |
|---|---|---|
| ADLAI NORTYE LTD. | Directeur/Membre du Conseil | 30/06/2024 |
| ACTUATE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 12/08/2024 |
| ARBUTUS BIOPHARMA CORPORATION | Directeur/Membre du Conseil | 04/08/2025 |
SIRPant Immunotherapeutics, Inc.
 SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops adoptive cell therapy | Directeur/Membre du Conseil | 01/01/2024 |
Neuvogen, Inc.
 Neuvogen, Inc. BiotechnologyHealth Technology Develops therapeutic cancer vaccines | Corporate Officer/Principal | - |
Anciens postes connus de Roger Sawhney
| Sociétés | Poste | Fin |
|---|---|---|
Garuda Therapeutics, Inc.
 Garuda Therapeutics, Inc. BiotechnologyHealth Technology Develops hematopoietic stem cell therapies to treat severe and life-threatening diseases | Directeur Financier/CFO | 01/12/2023 |
| ALIMERA SCIENCES, INC. | Directeur/Membre du Conseil | 24/03/2023 |
| OMEA THER | Directeur Financier/CFO | 23/05/2022 |
KKR Group Co., Inc.
 KKR Group Co., Inc. Investment ManagersFinance Provides private equity, infrastructure and real estate investment & provides asset management services | Directeur/Membre du Conseil | 01/02/2020 |
| ░░░░░░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Roger Sawhney
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
92
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Alimera Sciences, Inc.
 Alimera Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops, manufactures and commercializes therapeutics for ophthalmology, rheumatology, nephrology, neurology & pulmonology problems | Health Technology |
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
ContextMedia Health LLC
 ContextMedia Health LLC Medical/Nursing ServicesHealth Services Owns and operates a digital healthcare networks | Health Services |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bain & Co., Inc.
 Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategy, marketing, organization, operations, IT and M&A consulting services | Commercial Services |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
New York Institute of Technology
 New York Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KKR Group Co., Inc.
KKR Group Co., Inc. Investment ManagersFinance Provides private equity, infrastructure and real estate investment & provides asset management services | Finance |
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel therapeutics which target cancers and neurodegenerative diseases | Health Technology |
Arcellx, Inc.
 Arcellx, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies | Health Technology |
LB Pharmaceuticals, Inc.
 LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
SIRPant Immunotherapeutics, Inc.
SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops adoptive cell therapy | Health Technology |
Neuvogen, Inc.
Neuvogen, Inc. BiotechnologyHealth Technology Develops therapeutic cancer vaccines | Health Technology |
Adlai Nortye Ltd.
 Adlai Nortye Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biopharmaceuticals for cancer immunotherapy | Commercial Services |
Garuda Therapeutics, Inc.
Garuda Therapeutics, Inc. BiotechnologyHealth Technology Develops hematopoietic stem cell therapies to treat severe and life-threatening diseases | Health Technology |
